Clinical Trial Update: Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether 36 months of levocetirizine can prevent asthma in young children with eczema; the study was terminated and results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Atopic Dermatitis

Drugs mentioned

• Levocetirizine (Xyzal) (levocetirizine)

Snippet

Sponsor: UCB Pharma | Conditions: Asthma | Phase 3 | Status: TERMINATED | Results posted: 2009-08-04